Drreddys Laboratories | RDY - سود عملیاتی





سود عملیاتی تغییر دادن تاریخ
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Drreddys Laboratories INR 14.33B 2.51B 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 673M 243M 2025-06
Novartis USD 4.06B 437M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Richter Gedeon HUF 63.58B 6.08B 2025-09
Sun Pharmaceuticals INR 33.67B 49.9M 2025-09
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12